LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS

被引：0
|
作者：
Taylor, A. [1 ]
Nash, P. [2 ]
Hall, S. [3 ]
Jones, G. [4 ]
Youssef, P. [4 ]
Porter-Brown, B. [5 ]
Thompson, L. [5 ]
Genovese, M. [6 ]
机构：
[1] Royal Perth Hosp, Perth, WA, Australia
[2] Univ Queensland, Cotton Tree, Australia
[3] Cabrini Med Ctr, Malvern, Australia
[4] Menzies Res Inst, Hobart, Tas, Australia
[5] Roche, Welwyn Garden City, England
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    Van Vollenhoven, Ronald
    [J]. RHEUMATOLOGY, 2012, 51 : 75 - 76
  • [2] Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials.
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    van Vollenhoven, Ronald F.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S866
  • [3] New insights and long-term safety of tocilizumab in rheumatoid arthritis
    Jones, Graeme
    Panova, Elena
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (10) : 195 - 199
  • [4] SAFETY AND TOLERABILITY OF TOCILIZUMAB IN LONG-TERM EXTENSION STUDIES OF RHEUMATOID ARTHRITIS
    Nash, P.
    Taylor, A.
    Hall, S.
    Jones, G.
    Youssef, P.
    Genovese, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 : 17 - 17
  • [5] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS)
    van Vollenhoven, Ronald
    Scali, Juan
    Curtis, Jeffrey R.
    Krasnow, Joel
    Vernon, Emma
    Alten, Rieke
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1087 - 1087
  • [6] TOCILIZUMAB: ANALYSIS OF LONG-TERM EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS PATIENTS
    Chalmeta Verdejo, I.
    Gonzalez Puig, L.
    Labrador Sanchez, E.
    Feced Olmos, C. M.
    Grau Garcia, E.
    Ivorra Cortes, J.
    Martinez Cordellat, I.
    Negueroles Albuixech, R.
    Nunez-Cornejo Piquer, C.
    Ortiz Sanjuan, F. M.
    Valero Sanz, J. L.
    Arevalo Ruales, K.
    Alcaniz Escandell, C.
    Roman Ivorra, J. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1049 - 1049
  • [7] LONG-TERM SAFETY OF RITUXIMAB: FOLLOW UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS
    van Vollenhoven, Ronald
    Emery, Paul
    Bingham, Clifton, III
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Macey, Katherine M.
    Sweetser, Marianne T.
    Lehane, Patricia
    Farmer, Pamela
    Long, Simon G.
    [J]. RHEUMATOLOGY, 2011, 50 : 127 - 128
  • [8] Long-term safety of adalimumab (humira®) in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, A
    Kupper, H
    Spencer-Green, GT
    [J]. RHEUMATOLOGY, 2005, 44 : I70 - I71
  • [9] AN INTERIM ANALYSIS OF LONG-TERM EXTENSION TRIALS OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    van Vollenhoven, R. F.
    Smolen, J. S.
    Tony, H. P.
    Codding, C.
    Keystone, E. C.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    [J]. RHEUMATOLOGY, 2009, 48 : I86 - I87
  • [10] TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RATES OF MALIGNANCY: RESULTS FROM LONG-TERM EXTENSION CLINICAL TRIALS
    van Vollenhoven, Ronald F.
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Porter-Brown, Benjamin
    Rowell, Lucy
    Napalkov, Pavel
    Smart, Devi
    [J]. RHEUMATOLOGY, 2014, 53 : 91 - 92
12345